/ /

Cheryl Guttman Krader
At issue: Is MRSA testing and prophylaxis a worthwhile approach?
Although infections caused by methicillin-resistant Staphylococcus aureus (MRSA) are a prominent concern for cataract surgeons, leading ophthalmologists discuss the pros and cons of performing universal MRSA screening to guide targeted prophylaxis.
Presbyopic laser vision correction: Analyzing PRK method at 1 year
Multifocal bi-aspheric ablation profile, micromonovision approach delivers good outcomes
IVAN data mined for insights on intravitreal anti-VEGF systemic safety
IVAN data mined for insights on intravitreal anti-VEGF systemic safety
Analyses of data from the Inhibition of VEGF in Age-related Choroidal Neovascularisation trial conducted to explore relationships between temporal changes in serum VEGF and safety events showed that at 1 year, a larger fall from baseline serum VEGF was associated with a lower hazard of death.
Add-on sulcus-based IOL addresses ametropia post-cataract surgery
Kenneth J. Rosenthal, MD, explains the advantages of an add-on sulcus-based IOL for correcting refractive errors in eyes that have undergone cataract surgery with in-the-bag IOL implantation.
Aflibercept for DME effective therapy in VISTA, VIVID trials
Data from the phase III VISTA-DME trial show aflibercept 2 mg every 4 or every 8 weeks remains superior to laser photocoagulation and is associated with stable improvements in best-corrected visual acuity and macular thickness.
Ultra-widefield imaging adds value for telehealth programs
Ultra-widefield imaging adds value for telehealth programs
A retrospective cohort study found a significantly higher rate of detection of nondiabetic retinopathy findings using ultra-widefield retinal imaging compared with nonmydriatic fundus photography.
Immunotherapy for food allergy: Promise and progress
Immunotherapy for food allergy: Promise and progress
Allergen-specific immunotherapy, although still experimental, is becoming an area of active research for treatment of food allergy in children.
Anti-VEGF for DME durable to 3 years
Patients who receive intravitreal ranibizumab (Lucentis, Genentech) for treatment of diabetic macular edema over a 3-year period achieved rapid improvements in vision and edema.
Tips for toric IOL marking
Toric IOL implantation provides a reliably effective method for reducing existing astigmatism in patients undergoing cataract surgery, but careful marking of the eye to guide accurate axis alignment of the IOL is essential for achieving good outcomes, said Bonnie An Henderson, MD.
What’s next in the neovascular AMD pipeline?
The therapeutic pipeline for neovascular age-related macular degeneration (AMD) contains a host of promising investigational agents. Only time will tell how any one will shape the future of AMD management.